A loss‐of‐function mutation in the CBP/CREBBP gene, which encodes a HAT, is common to many cancers, including GC [82], and MAP2K4 loss of expression has been reported in gastric adenocarcinoma associated with poor survival [81]. This evidence concerns the gene MAP2K4 and gastric adenocarcinoma.